Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction? [7] (multiple letters)
No Thumbnail Available
Date
2003
Journal Title
Journal ISSN
Volume Title
Publisher
Access Rights
info:eu-repo/semantics/openAccess
Abstract
[No abstract available]
Description
Keywords
angiotensin 1 receptor antagonist, atenolol, captopril, dipeptidyl carboxypeptidase inhibitor, indapamide, losartan, perindopril, thiazide diuretic agent, anamnesis, cell protection, clinical trial, comorbidity, disease association, disease course, drug efficacy, human, kidney disease, kidney function, letter, mortality, priority journal, recurrent disease, risk assessment, stroke, sudden death, treatment outcome, treatment planning, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Cerebrovascular Accident, Clinical Trials, Humans, Indapamide, Kidney Diseases, Perindopril, Ramipril, Receptor, Angiotensin, Type 1, Receptors, Angiotensin
Journal or Series
Stroke
WoS Q Value
Scopus Q Value
Q1
Volume
34
Issue
1
